Left ventricular global function index by magnetic resonance imaging — a novel marker for differentiating cardiac amyloidosis from hypertrophic cardiomyopathy

Differentiating cardiac amyloidosis (CA) from hypertrophic cardiomyopathy (HCM) remains a clinical challenge, particularly in those with preserved left ventricular ejection fraction (LVEF) and similar hypertrophy. This study aimed to use left ventricular global function index (LVGFI) and myocardial...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shan, Xu, Hua-yan, Diao, Kai-yue, Shi, Ke, He, Yong, He, Sen, Zhang, Yi, Gao, Yue, Shen, Meng-ting, Guo, Ying-kun, Yang, Zhi-gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069935/
https://www.ncbi.nlm.nih.gov/pubmed/32170130
http://dx.doi.org/10.1038/s41598-020-61608-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069935/
https://www.ncbi.nlm.nih.gov/pubmed/32170130
http://dx.doi.org/10.1038/s41598-020-61608-9

Ejemplares similares